Viewing register:

PPB

Marketing Authorisation Holder

Mylan Laboratories Limited, Mylan Laboratories Limited Plot No. H-12 & H-13

INDIA

4

Total Medicines

0

Active

2

Dosage Forms

1

Country

Ghana (4)

Registration Status

Valid 4

Dosage Forms

Sitagliptin / Metformin Hydrochloride 50/500mg 3 Dolutegravir Sodium 50mg/ Lamivudine 300mg/ Tenovofir Alafenamide Fumarate 25mg 1

Local Agents / Applicants

Worldwide Healthcare... 4

Registered Medicines

Showing 4 of 4

Product	Form / Strength	Country	Reg. Number	Status
ENVUTEG TABLETS (Each film coated tablet contains Dolutegravir Sodium 50mg/ Lamivudine 300mg/ Tenovofir Alafenamide Fumarate 25mg Dolutegravir Sodium 50mg/ Lamivudine 300mg/ Tenovofir Alafenamide Fumarate 25mg	Dolutegravir Sodium 50mg/ Lamivudine 300mg/ Tenovofir Alafenamide Fumarate 25mg 50mg/ 300mg/25mg	Ghana	FDA/SD.265-070650	Valid
SITAZUCA MH 50/1000 TABLETS (Each film-coated tablet contains Sitagliptin / Metformin Hydrochloride 50/1000mg) Sitagliptin / Metformin Hydrochloride 50/500mg	Sitagliptin / Metformin Hydrochloride 50/500mg 50/1000mg	Ghana	FDA/SD.265-050565	Valid
SITAZUCA MH 50/500 TABLETS (Each film-coated tablet contains Sitagliptin / Metformin Hydrochloride 50/500mg) Sitagliptin / Metformin Hydrochloride 50/500mg	Sitagliptin / Metformin Hydrochloride 50/500mg 50/500mg	Ghana	FDA/SD.265-050563	Valid
SITAZUCA MH 50/850 TABLETS (Each film-coated tablet contains Sitagliptin / Metformin Hydrochloride 50/850mg) Sitagliptin / Metformin Hydrochloride 50/500mg	Sitagliptin / Metformin Hydrochloride 50/500mg 50/850mg	Ghana	FDA/SD.265-050564	Valid